See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.73▲ 1.83%
← TMV page
XStocksXray
Market X-Ray report · 27 October 2026

TeamViewer AG (TMV)

Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026

Key indicators

Last closeEUR 7.625
52-week range4.086 – 7.740
Return, 1 month / 3 months+23.9% / +29.8%
Return, 1 year / 3 years+16.6% / −47.2%
TrendUptrend
RSI (14)74
Volatility (1 year)45.8%
Worst drawdown (1 year)-35.0%
Average daily value traded4.05M EUR
Dividend yield–

Market X-Ray price-based

72/ 100 · High confidence · ahead of 89% of stocks on this exchange
Trend96
Momentum78
Stability (higher is calmer)35
Liquidity84
Income–

Five-year price chart navy: price · brown: 200-day average

3.417.1110.8014.5018.192021-112023-022024-052025-082026-10

About the company

TeamViewer is a software company based in Germany that develops remote connectivity and collaboration tools. Its products let people access and control computers and devices from elsewhere, support help desks and IT teams, and run online meetings and remote maintenance. Customers range from small businesses to large organisations across many industries, who use the software for technical support, device management and keeping distributed teams connected.

The shares are listed on the Deutsche Börse Xetra in Germany under the code TMV, and the price on this page is in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

TeamViewer AG (TMV) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 7.625 on 27 October 2026.

Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 76 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 16.6% and over the last three months it rose 29.8%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
TeamViewer AG (TMV)

The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra

Lens and metricValueScoreReading
Trend96 · StrongTrading above its long-term averages and near its highs.
Above 200-day average34.7%
From 52-week high-0.1%
Momentum78 · StrongRising faster than most stocks on this exchange.
3-month return29.8%
6-month return59.7%
12-month return, skipping the last month-5.9%
Stability (higher is calmer)35 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)45.8%
Worst drawdown, 1 year (smaller is calmer)-35.0%
Liquidity84 · StrongTrades actively.
Average daily value traded4.05M EUR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.
  • Liquidity: Trades actively.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+8.5%
1 month+23.9%
3 months+29.8%
6 months+59.7%
1 year+16.6%
3 years−47.2%
5 years−40.8%

Signals

50-day / 200-day average6.716 / 5.663
Golden / death cross (60 days)None
New 52-week highYes
Bullish RSI divergenceNo
Average daily range (ATR)0.264

Technical summary

DailyBullish12 bullish · 0 neutral · 4 bearish
WeeklyBullish8 bullish · 1 neutral · 3 bearish
MonthlyBullish5 bullish · 1 neutral · 2 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026